Browsing publications by Dr David Sheridan

Newcastle AuthorsTitleYearFull text
Emeritus Professor Margaret Bassendine
Dr Soren Nielsen
Dr Simon Bridge
Dr Daniel Felmlee
Dr David Sheridan
et al.
Hepatitis C virus and atherosclerosis: A legacy after virologic cure?2017
Dr Luca Miele
Dr David Sheridan
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes2016
Dr David Sheridan
FibroGENE: A gene-based model for staging liver fibrosis2016
Dr David Sheridan
Fiona Fenwick
Emeritus Professor Margaret Bassendine
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection2016
Professor Quentin Anstee
Dr David Sheridan
Staging fibrosis and excluding advanced fibrosis in patients with NAFLD: comparison of non-invasive markers in an interim analysis from a prospective multicentre study2016
Dr David Sheridan
Professor Margaret Bassendine
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease2015
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
Emeritus Professor Margaret Bassendine
et al.
Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency2014
Dr David Sheridan
Emeritus Professor Margaret Bassendine
Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection2014
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Fiona Fenwick
Dr R Neely
et al.
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial2014
Professor Margaret Bassendine
Dr David Sheridan
Jaime Jonsson
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection2013
1234